市場調査レポート
商品コード
1078044
世界の心臓アブレーション市場(2022年~2028年)Global Cardiac Ablation Market 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
世界の心臓アブレーション市場(2022年~2028年) |
出版日: 2022年04月13日
発行: Orion Market Research
ページ情報: 英文 120 Pages
納期: 2~3営業日
|
世界の心臓アブレーションの市場規模は、予測期間中にCAGRで10.7%の大幅な成長が予測されています。高齢者人口の増加、心血管系疾患の有病率の上昇、アブレーションデバイス分野における技術的進歩が、市場成長を促進しています。
当レポートでは、世界の心臓アブレーション市場について調査分析し、市場概要、競合情勢、セグメント分析、地域分析などを提供しています。
Global Cardiac Ablation Market Size, Share & Trends Analysis Report By Technology (Cryoablation, Radio Frequency Ablation, Microwave Ablation, and Ultrasound Ablation), By Application (Cardiac Rhythm Management and Open Surgery) Forecast Period (2022-2028)
The global cardiac ablation market is anticipated to grow at a significant CAGR of 10.7% during the forecast period. The increasing elderly population, coupled with the rise in cardiovascular disorders and technological advancements in the field of ablation devices, are driving the market growth. Government policies and healthcare reforms in the U. S. are propelling the market further. Vendors involved in the manufacturing and marketing of cardiac ablation products have growth potential in emerging nations such as India, China, and Mexico. The cardiac ablation industry is seeing growth due to factors such as increased use of ablation in the treatment of heart diseases and increased product market penetration.
The global cardiac ablation market is segmented based on technology and application. Based on technology, the market is segmented into cryoablation, radiofrequency ablation, microwave ablation, and ultrasound ablation. Radiofrequency ablation is expected to hold significant share in the market. Further, based on application, the market is bifurcated into cardiac rhythm management and open surgery. Cardiac rhythm management includes cardiac arrhythmia, atrial fibrillation and flutter, and tachycardia.
The global cardiac ablation market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the North American regional market is expected to witness notable growth during the forecast period. The regional growth is attributed to the rising burden of cardiovascular diseases along with growing number of patient pool. Moreover, rising healthcare expenditureand advancement in healthcare technologies are further driving the market.
The major companies serving the global cardiac ablation market include Medtronic PLC, Koninklijke Phillips NV, Boston Scientific Corp., Abbott Laboratories Inc., and Johnson & Johnson Services, Inc., among others. among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2019, Johnson & Johnson's Biosense Webster unveiled the "CARTONET platform," a cutting-edge cloud-based cardiac ablation data network that connects devices and shares data in the field.
Research Methodology
The market study of the global cardiac ablation market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of the market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
Global Cardiac Ablation Market Size, Share & Trends Analysis Report By Technology (Cryoablation, Radio Frequency Ablation, Microwave Ablation, and Ultrasound Ablation), By Application (Cardiac Rhythm Management and Open Surgery) Forecast Period (2022-2028)
The global cardiac ablation market is anticipated to grow at a significant CAGR of 10.7% during the forecast period. The increasing elderly population, coupled with the rise in cardiovascular disorders and technological advancements in the field of ablation devices, are driving the market growth. Government policies and healthcare reforms in the U. S. are propelling the market further. Vendors involved in the manufacturing and marketing of cardiac ablation products have growth potential in emerging nations such as India, China, and Mexico. The cardiac ablation industry is seeing growth due to factors such as increased use of ablation in the treatment of heart diseases and increased product market penetration.
The global cardiac ablation market is segmented based on technology and application. Based on technology, the market is segmented into cryoablation, radiofrequency ablation, microwave ablation, and ultrasound ablation. Radiofrequency ablation is expected to hold significant share in the market. Further, based on application, the market is bifurcated into cardiac rhythm management and open surgery. Cardiac rhythm management includes cardiac arrhythmia, atrial fibrillation and flutter, and tachycardia.
The global cardiac ablation market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the North American regional market is expected to witness notable growth during the forecast period. The regional growth is attributed to the rising burden of cardiovascular diseases along with growing number of patient pool. Moreover, rising healthcare expenditureand advancement in healthcare technologies are further driving the market.
The major companies serving the global cardiac ablation market include Medtronic PLC, Koninklijke Phillips NV, Boston Scientific Corp., Abbott Laboratories Inc., and Johnson & Johnson Services, Inc., among others. among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2019, Johnson & Johnson's Biosense Webster unveiled the "CARTONET platform," a cutting-edge cloud-based cardiac ablation data network that connects devices and shares data in the field.
Research Methodology
The market study of the global cardiac ablation market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of the market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
Category- Medical Devices